Blood Money: Green Cross Invests $180 Million for Montreal Blood Plasma Fractionation Plant
SUGAR LAND--May 13, 2015--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--Blood red is the new money green, if construction investment in plasma fractionation is any indication. Adding to a spike of construction activity in this industry segment, biopharmaceutical company Green Cross (Yongin, South Korea) has chosen Montreal, Quebec, for its new, $180 million plasma fractionation plant.
Within this article: Details on the Green Cross project and the booming plasma fractionation market.
